(Q41655370)

6 October 2017

1 reference

title

Rotavirus vaccines against diarrhoeal disease (English)

1 reference

6 October 2017

1 reference

T Vesikari

1

1 reference

6 October 2017

language of work or name

English

0 references

publication date

1 November 1997

1 reference

6 October 2017

1 reference

6 October 2017

volume

350

1 reference

6 October 2017

issue

9090

1 reference

6 October 2017

page(s)

1538-1541

1 reference

Field trial of a locally produced, killed, oral cholera vaccine in Vietnam

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903254-6

7 January 2021

Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903254-6

7 January 2021

Rotavirus infection in infants as protection against subsequent infections

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903254-6

7 January 2021

Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903254-6

7 January 2021

Protection conferred by neonatal rotavirus infection against subsequent rotavirus diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903254-6

7 January 2021

Protection Studies in Colostrum-Deprived Piglets of a Bovine Rotavirus Vaccine Candidate Using Human Rotavirus Strains for Challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903254-6

7 January 2021

Immunogenicity and safety of live oral attenuated bovine rotavirus vaccine strain RIT 4237 in adults and young children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903254-6

7 January 2021

Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903254-6

7 January 2021

Review of rotavirus vaccine trials in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903254-6

7 January 2021

Failure of live, attenuated oral rotavirus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903254-6

7 January 2021

Protection of Peruvian children against rotavirus diarrhea of specific serotypes by one, two, or three doses of the RIT 4237 attenuated bovine rotavirus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903254-6

7 January 2021

Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903254-6

7 January 2021

Evaluation of the efficacy of a low-passage bovine rotavirus (strain WC3) vaccine in children in Central Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903254-6

7 January 2021

Rotavirus: the major etiologic agent of severe infantile diarrhea may be controllable by a "Jennerian" approach to vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903254-6

7 January 2021

A comparative trial of rhesus monkey (RRV-1) and bovine (RIT 4237) oral rotavirus vaccines in young children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903254-6

7 January 2021

Field trial of rhesus rotavirus vaccine in infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903254-6

7 January 2021

Prolonged efficacy of rhesus rotavirus vaccine in Swedish children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903254-6

7 January 2021

Efficacy of a quadrivalent rhesus rotavirus-based human rotavirus vaccine aimed at preventing severe rotavirus diarrhea in infants and young children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903254-6

7 January 2021

Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903254-6

7 January 2021

Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903254-6

7 January 2021

Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903254-6

7 January 2021

Safety, Immunogenicity, and Protective Efficacy of One and Three Doses of the Tetravalent Rhesus Rotavirus Vaccine in Infants in Lima, Peru

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903254-6

7 January 2021

Mechanisms of protection against rotavirus in humans and mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903254-6

7 January 2021

Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903254-6

7 January 2021

Molecular determinants of immunity and pathogenicity of rotavirus infection in the mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903254-6

7 January 2021

Immune response to rotavirus polypeptides after vaccination with heterologous rotavirus vaccines (RIT 4237, RRV-1)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903254-6

7 January 2021

Host factors associated with protection against rotavirus disease: the skies are clearing

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903254-6

7 January 2021

Anti-rotavirus G type-specific and isotype-specific antibodies in children with natural rotavirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903254-6

7 January 2021

Lack of correlation between serum rotavirus antibody titers and protection following vaccination with reassortant RRV vaccines. US Rotavirus Vaccine Efficacy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903254-6

7 January 2021

Simultaneous administration of oral rhesus-human reassortant tetravalent (RRV-TV) rotavirus vaccine and oral poliovirus vaccine (OPV) in Thai infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903254-6

7 January 2021

Hospital admissions attributable to rotavirus infection in England and Wales

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903254-6

7 January 2021

The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903254-6

7 January 2021

Virus-like particles as a rotavirus subunit vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903254-6

7 January 2021

Protection against rotavirus infections by DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903254-6

7 January 2021

10.1016/S0140-6736(97)03254-6

Identifiers

DOI

1 reference

6 October 2017

1 reference